Concepedia

A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen

Yae Jee Baek, Woojoong Kim, Jae‐Hoon Ko, Youn-Jung Lee, Jin Young Ahn, Jung Ho Kim, Ho Cheol Jang, Hye Won Jeong, Yong Chan Kim, Yoon Soo Park,

Vaccine · 2023 · 12 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.5K citations · Full text

, , +17

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury, Deborah Cromer, Arnold Reynaldi et al. · Nature Medicine · 2021 · 4.2K citations · Full text

, , +16

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher, Thomas Thiele, Theodore E. Warkentin et al. · New England Journal of Medicine · 2021 · 2.3K citations · Full text

, , +12

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

Nina Haagenrud Schultz, Ingvild Hausberg Sørvoll, Annika E. Michelsen et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text

, , +14

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer, Komal Srivastava, Hala Alshammary et al. · New England Journal of Medicine · 2021 · 803 citations · Full text

, , +16